For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Agilon Health Inc (NYSE: AGL) closed at $2.23 in the last session, up 0.45% from day before closing price of $2.22. In other words, the price has increased by $0.45 from its previous closing price. On the day, 4.52 million shares were traded.
Ratios:
We take a closer look at AGL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.01.
On April 08, 2025, Bernstein Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $8.50.
Citigroup Upgraded its Sell to Neutral on January 10, 2025, whereas the target price for the stock was revised from $1.75 to $2.25.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 13 ’24 when McLoughlin Karen bought 25,000 shares for $2.20 per share. The transaction valued at 55,085 led to the insider holds 73,166 shares of the business.
Battaglia Silvana bought 25,062 shares of AGL for $50,269 on Dec 11 ’24. The Director now owns 66,144 shares after completing the transaction at $2.01 per share. On Nov 25 ’24, another insider, MCKENZIE DIANA, who serves as the Director of the company, bought 12,500 shares for $2.28 each. As a result, the insider paid 28,474 and bolstered with 51,319 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.15 while its Price-to-Book (P/B) ratio in mrq is 1.84.
Stock Price History:
Over the past 52 weeks, AGL has reached a high of $7.73, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is -43.22%, while the 200-Day Moving Average is calculated to be -33.04%.
Shares Statistics:
A total of 413.02M shares are outstanding, with a floating share count of 302.78M. Insiders hold about 26.86% of the company’s shares, while institutions hold 73.47% stake in the company.
Earnings Estimates
The stock of Agilon Health Inc (AGL) is currently drawing attention from 8.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.04 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.13 and -$0.48 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.21, with 11.0 analysts recommending between -$0.01 and -$0.4.
Revenue Estimates
According to 16 analysts, the current quarter’s revenue is expected to be $1.47B. It ranges from a high estimate of $1.5B to a low estimate of $1.46B. As of the current estimate, Agilon Health Inc’s year-ago sales were $1.48BFor the next quarter, 16 analysts are estimating revenue of $1.46B. There is a high estimate of $1.51B for the next quarter, whereas the lowest estimate is $1.43B.
A total of 19 analysts have provided revenue estimates for AGL’s current fiscal year. The highest revenue estimate was $6.03B, while the lowest revenue estimate was $5.9B, resulting in an average revenue estimate of $5.96B. In the same quarter a year ago, actual revenue was $6.06BBased on 19 analysts’ estimates, the company’s revenue will be $6.6B in the next fiscal year. The high estimate is $7.2B and the low estimate is $6.01B.
